Uveitis: all 345 studies

Page 2 of 4. Open to participants first (38), then studies with results posted, then the rest; newest registration first within each.

• Adalimumab (Humira) in the Treatment of Refractory Non-infectious UveitisCompletedNCT00525902Phase 2Results posted
• Lucentis for Inflammatory Macular Edema TrialCompletedNCT00498355Phase 1/2Results posted
• Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory MedicationsCompletedNCT00476593Not applicableResults posted
• A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior UveitisCompletedNCT00333814Phase 2/3Results posted
• Efalizumab to Treat UveitisCompletedNCT00280826Phase 1Results posted
• Multicenter Uveitis Steroid Treatment (MUST) TrialCompletedNCT00132691Phase 4Results posted
• Human Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated UveitisCompletedNCT00130637Phase 2Results posted
• Oftac Eye Drops (0.05% Tacrolimus Ophthalmic Emulsion) for the Treatment of Active Non-infectious Anterior UveitisCompletedNCT07869953Phase 1/2
• Real-World Incidence of Intraocular Inflammation Following Intravitreal Treatment With Aflibercept 8 mgCompletedNCT07849309
• An Interventional Study of Upadacitinib Extended-Release Tablets in Patients With Refractory UveitisActive, not recruitingNCT07773623Phase 4
• Targeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine ProfilesActive, not recruitingNCT07262437Not applicable
• A Study of REGN7041 for Active Noninfectious Uveitis in Adult ParticipantsTerminatedNCT07218770Phase 1/2
• Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in SingaporeActive, not recruitingNCT07176130
• Characteristics of Ankylosing Spondylitis Associated UveitisCompletedNCT07113834
• Real-world Incidence of Intraocular Inflammation Following Intravitreal Faricimab TherapyCompletedNCT06902207
• Study of Risk Factors for Therapeutic Failure in Chronic Non-Infectious Uveitis After First-Line Immunosuppressive TherapyActive, not recruitingNCT06821971
• Incidence of Macular Edema in a Uveitis PopulationActive, not recruitingNCT06686641
• A Phase 2 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior UveitisCompletedNCT06679153Phase 2
• Six-months Versus Nine-months ATT for Ocular TBCompletedNCT06613919Phase 4
• Vitamin and Unsaturated Fatty Acid Supplements in Healthy and Uveitis Human SubjectsCompletedNCT06491979Not applicable
• A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior UveitisActive, not recruitingNCT06431373Phase 3
• Effect of Immunosuppressants With Adalimumab Biosimilars vs Corticosteroids on Noninfectious UveitisCompletedNCT06310837Not applicable
• Different Treatment Approaches of Presumed Trematode-Induced UveitisActive, not recruitingNCT06260449Not applicable
• Analysis of Ocular Complications of AIDS Patients in Ophthalmic ConsultationActive, not recruitingNCT06250881
• Nailfold Capillaroscopic Assessment in Pediatric Uveitis PatientsCompletedNCT06070935
• A Study of the Incidence of Intraocular Inflammation and Suspected Endophthalmitis Among Patients Treated With Aflibercept, Vial and Pre-filled Syringe, 2014-2022CompletedNCT05791695
• The Cohort Study of Uveitis PatientsCompletedNCT05727540
• Safety and Efficacy of Adalimumab Therapy for Treatment of Behcet's Disease-related Uveitis in Sohag University HospitalStatus unknownNCT05683626
• Analysis of Imaging Features From Patients Treated With Brolucizumab in the Post-marketing Setting With Reports of Retinal Vasculitis and/or Retinal Vascular OcclusionCompletedNCT05657158
• A Study of the Effect of Different Doses of Difluprednate Eye Drops on the Intraocular Pressure After PhacoemulsificationStatus unknownNCT05649111Phase 4
• Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular EdemaActive, not recruitingNCT05608837Phase 2
• Biologic Therapy in Pediatric JIA UveitisStatus unknownNCT05540743Phase 4
• A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior UveitisCompletedNCT05523765Phase 2
• The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior SegmentCompletedNCT05486468Phase 3
• A Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Participants Requiring High Dose Corticosteroids for Active Non-Infectious Intermediate, Posterior, or Pan-UveitisCompletedNCT05414201Phase 4
• Screening for Oculocerebral Lymphoma With the Phenotype of NK Cells in Patients With UveitisCompletedNCT05388838Not applicable
• UNICORNS: Uveitis in Childhood Prospective National Cohort StudyActive, not recruitingNCT05385757
• Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitisTerminatedNCT05384249Phase 2
• Retrospective Comparison of the Efficacy of Methotrexate and Azathioprine as Background Treatment for Uveitis of Undetermined Origin: Single-centre Retrospective Study From 2005 to 2020Status unknownNCT05370690
• Outcome of Treatment of Uveitis With Biologic Drugs in Resistant Cases Vogt-koyanagi-Harada DiseaseStatus unknownNCT05349747
• Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment UveitisActive, not recruitingNCT05322070Phase 4
• Assessment of Safety , Clinical Efficacy With QLETLI in Non-infectious Uveitis (UV)CompletedNCT05180526Phase 4
• Reduction or Discontinuation of TNF-α Inhibitor in Non-infectious Uveitis PatientsStatus unknownNCT05155592Phase 2
• High Resolution Optical Coherence TomographyStatus unknownNCT05130385
• Mutation Detection for VRLStatus unknownNCT05102994
• Ozurdex Monotherapy TrialWithdrawnNCT05101928Phase 4
• The Efficacy and Safety of Adalimumab in Non-infectious Anterior Pediatric Uveitis With Peripheral Vascular LeakageStatus unknownNCT05015335Phase 4
• The Effectivity of Anti Tuberculosis Therapy in Idiopathic Uveitis with Positive IGRACompletedNCT05005637Phase 2
• Stepped Surgery in Uveitic Cataract: A Novel Approach to a Quiet EyeCompletedNCT04931277Not applicable
• Intraocular Fluid Detection in EndophthalmitisStatus unknownNCT04914884
• Microbiome as a ThErapeutic Response BiomarkerWithdrawnNCT04721743
• A Trial of the Efficacy and Safety of Izokibep in the Treatment of Non-anterior UveitisCompletedNCT04706741Phase 2
• Development of AI Model for Uveitis Progression and PrognosisStatus unknownNCT04705103
• Imaging Quantification of Inflammation (IQI)Active, not recruitingNCT04704609
• Biomarkers in Ocular Inflammation and UveitisCompletedNCT04690829
• Adalimumab Plus Methotrexate for the Treatment of Pediatric UveitisStatus unknownNCT04588818Phase 2
• Evaluation of DEXTENZA in the Management of Pain and Inflammation in Patients With Anterior Uveitis Compared to Standard of Care Topical CorticosteroidsStatus unknownNCT04426734Phase 4
• Soluble CD95 Ligand Role in the Pathophysiology of Non-infectious Active UveitisCompletedNCT04354909
• Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide ImplantCompletedNCT04340505
• Outcome of Cataract Surgery With UveitisStatus unknownNCT04333069Not applicable
• Effects of Conbercept in Refractory Uveitic Macular Edema and VEGFTerminatedNCT04296838Phase 2/3
• Golimumab for the Treatment of Refractory Behcet's UveitisTerminatedNCT04218565Phase 2
• A 48 Week Study to Evaluate the Efficacy and Safety of Two (2) EYS606 Treatment Regimens in Subjects With Active Chronic Non-infectious Uveitis (CNIU)CompletedNCT04207983Phase 2
• Simvastatin in UveitisCompletedNCT04183387Phase 2
• Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Non-infectious and Idiopathic UveitisStatus unknownNCT04162314Phase 2/3
• A Clinical Trial of Infliximab for Childhood UveitisStatus unknownNCT04150770Phase 4
• Medication Compliance in the Paediatric Uveitis Population Reported by the Patients and ParentsCompletedNCT04148365
• Pilot Project: The Amplicon and Metatranscriptomic Study of Intra and Extra Intestinal Microbiome in Non-infectious Uveitis DiseaseStatus unknownNCT04126850
• Multicenter, Randomized Study Evaluating the Value of Antitubercular Treatment During Recurent Anterior Uveitis (URBA)Status unknownNCT04117698Phase 3
• Biomarkers of Common Eye DiseasesStatus unknownNCT04101604
• Comparison of PK and Tolerability of MSB11022 Administered by AI or PFSCompletedNCT04018599Phase 1
• Dexamethasone Intravitreal Implant (Ozurdex®) for Recurrent Vogt-Koyanagi-Harada (VKH) Disease Posterior UveitisCompletedNCT03971279
• Spontaneous Coronary Artery Dissection (SCAD) and AutoimmunityCompletedNCT03941184
• Monitoring Drug-induced UveitisCompletedNCT03899922
• Objective Choroidal Thickness Measurements in UveitisActive, not recruitingNCT03889860
• Abatacept in Patients With Birdshot HLA A29 UveitisCompletedNCT03871361Phase 2
• A Multicenter Phase 2 Single-arm Proof-of-concept Trial to Assess the Efficacy and Safety of Ustekinumab in Association With Prednisone for the Treatment of Non-infectious Severe Uveitis (NISU)TerminatedNCT03847272Phase 2
• Ocular Manifestations in Rheumatic DiseasesCompletedNCT03753893
• Epidemiology and Clinical Features of Uveitis in a Tertiary ReferralCompletedNCT03646890
• Feasibility Study and Preliminary Application Study on Iris OCTAStatus unknownNCT03631108
• Suprachoroidal Injection of Triamcinolone Acetonide Using Custom Made Needle to Treat Retinal DisordersStatus unknownNCT03606733Not applicable
• High-dose Intravitreal Injection of Ganciclovir for the Treatment of CMVR in HIV-negative PatientsCompletedNCT03598452Not applicable
• Psychosocial Outcomes and Transition Readiness in UveitisCompletedNCT03554824
• Tocilizumab for the Treatment of Refractory Behcet's UveitisTerminatedNCT03554161Phase 2
• OCT Technology Development to Assess Ocular Integrity and Characterize Ocular Integrity and Intraocular ScatterersCompletedNCT03531853Not applicable
• A Clinical Trial of Metformin to Decrease Glucocorticoids Side Effects in Patients With Autoimmune UveitisStatus unknownNCT03525028Not applicable
• (ACTH) for the Treatment of Sarcoid UveitisStatus unknownNCT03473964
• Demographics and Clinical Characteristics of Paediatric Intraocular Inflammation in SingaporeCompletedNCT03472781
• A Clinical Trial of Acyclovir for Viral UveitisStatus unknownNCT03389191Not applicable
• Immunologic Markers for the Differential Diagnosis Between Uveitis-TBC and Uveitis-SARC (TBC-SARC)CompletedNCT03346018
• Evaluation of EYS606 in Patients With Non-infectious Posterior, Intermediate or PanuveitisCompletedNCT03308045Phase 1/2
• Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease UveitisCompletedNCT03209219Phase 3
• RNFL Thickness Measurements Obtained Using SD-OCT and SLP Using GDx Variable Corneal CompensationCompletedNCT03206268
• Chronic Inflammatory Disease, Lifestyle and Treatment ResponseCompletedNCT03173144
• Impact of Humira® Therapy on Ocular Inflammation, Selected Health Care Resource Utilization and Patient Reported Outcomes in Patients With Active Non-infectious Intermediate, Posterior and Panuveitis in Routine Clinical PracticeCompletedNCT03155243
• Corneal Endothelial Cell Density in Eyes Treated With a Fluocinolone Acetonide Intravitreal ImplantCompletedNCT03145025
• Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal VasculitisStatus unknownNCT03066869Phase 4
• Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin HospitalCompletedNCT02998398
• Outcome of Different IOLs in Patients With and Without UveitisCompletedNCT02975895Not applicable
• Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the EyeTerminatedNCT02951975

← Uveitis overview